Latest news

| Thursday, December 19th 2019

Herantis Pharma Plc completes patient treatments in main study of Phase 1-2 CDNF trial in Parkinson’s disease

Read More
| Monday, November 11th 2019

EPDA European projects – TreatER

Read More
| Thursday, September 19th 2019

Renishaw’s neuroinfuseTM drug delivery system shortlisted for Healthcare Award

Read More
| Monday, September 2nd 2019

Trials on track as CDNF readout nears

Read More
| Tuesday, May 14th 2019

Prof. Mart Saarma – Unconventional Endoplasmic Reticulum Located Trophic Factor for Parkinson’s Disease

Read More
| Wednesday, April 10th 2019

Novel drug delivered direct to brain may halt Parkinson’s

Read More
| Tuesday, January 8th 2019

H2020 funding for clinical development – case Herantis Pharma

Read More